瑞康医药董秘李喆留置变更为责令候查

Core Viewpoint - Ruikang Pharmaceutical Group Co., Ltd. has received a notice from the Jiyang District Supervisory Committee in Jinan, which has changed the detention measures against its director, board secretary, and vice president Li Zhe to a directive for pending investigation [1] Summary by Relevant Sections - Company Announcement - Ruikang Pharmaceutical disclosed that the Jiyang District Supervisory Committee has lifted the detention measures on Li Zhe, changing it to a directive for pending investigation [1] - Background of Li Zhe - Li Zhe, born in 1986, holds a master's degree and has previously worked as a financial advisor at Sun Life Financial in Montreal, a fund management specialist at Canadian Imperial Bank of Commerce in Toronto, and an investment banking project manager at Guojin Securities in Shanghai [1]